These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 6401892

  • 21. Studies on the influence of reactants and buffer environment on clot lysis induced by human plasminogen activators.
    Westlund LE, Andersson LO.
    Thromb Res; 1985 Jan 01; 37(1):213-23. PubMed ID: 4039077
    [Abstract] [Full Text] [Related]

  • 22. [A hybrid molecule of pro-urokinase and a fibrin-specific, monoclonal antibody fragment is a more effective thrombolytic agent than pro-urokinase in vitro and in vivo].
    Bode C, Eberle T, Runge M, Haber E, Kübler W.
    Verh Dtsch Ges Inn Med; 1990 Jan 01; 96():1-3. PubMed ID: 2128723
    [No Abstract] [Full Text] [Related]

  • 23. Comparative study of different urokinase preparations.
    Millar WT, Smith JF.
    Thromb Res; 1983 Jun 01; 30(5):425-9. PubMed ID: 6351343
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV, Barrertt-Bergshoeff M, Hekkenberg RT, Rijken DC.
    Thromb Haemost; 1999 Apr 01; 81(4):605-12. PubMed ID: 10235448
    [Abstract] [Full Text] [Related]

  • 28. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
    Trübestein G, Popov S, Wolf H, Welzel D.
    Haemostasis; 1987 Apr 01; 17(4):238-44. PubMed ID: 2442078
    [Abstract] [Full Text] [Related]

  • 29. Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA).
    Fox KA, Bergmann SR, Sobel BE.
    Biochem Pharmacol; 1984 Jun 15; 33(12):1831-8. PubMed ID: 6233982
    [No Abstract] [Full Text] [Related]

  • 30. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R, Black J, Gurewich V.
    J Clin Invest; 1988 Mar 15; 81(3):853-9. PubMed ID: 2963831
    [Abstract] [Full Text] [Related]

  • 31. Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis.
    Gurewich V, Pannell R.
    Thromb Haemost; 2009 Aug 15; 102(2):279-86. PubMed ID: 19652878
    [Abstract] [Full Text] [Related]

  • 32. Nonradical excited oxygen species induce selective thrombolysis in vivo.
    Stief TW.
    Thromb Res; 1991 May 01; 62(3):147-63. PubMed ID: 1716380
    [Abstract] [Full Text] [Related]

  • 33. Enhancement of vitreous clot lysis by urokinase: mode of action.
    Forrester JV, Edgar W, Millar W, Prentice CR, Williamson J.
    Exp Eye Res; 1982 Jun 01; 34(6):895-907. PubMed ID: 6211365
    [No Abstract] [Full Text] [Related]

  • 34. Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activator.
    Westlund LE, Lundén R, Wallén P.
    Haemostasis; 1982 Jun 01; 11(4):235-41. PubMed ID: 6982199
    [Abstract] [Full Text] [Related]

  • 35. Effects of aspirin and prostaglandin E1 on in vitro thrombolysis with urokinase. Evidence for a possible role of inhibiting platelet activity in thrombolysis.
    Terres W, Beythien C, Kupper W, Bleifeld W.
    Circulation; 1989 Jun 01; 79(6):1309-14. PubMed ID: 2720929
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro.
    Lourenço DM, Dosne AM, Kher A, Samama M.
    Thromb Haemost; 1989 Nov 24; 62(3):923-6. PubMed ID: 2556812
    [Abstract] [Full Text] [Related]

  • 38. Influence of detergents on the measurement of the fibrinolytic activity of plasminogen activators.
    Kruithof EK, Ransijn A, Bachmann F.
    Thromb Res; 1982 Oct 15; 28(2):251-60. PubMed ID: 6891111
    [Abstract] [Full Text] [Related]

  • 39. Kinetics of urokinase-induced thrombolysis in a biphasic in vitro system.
    Iga Y, Stella SR, Chandler AB.
    Haemostasis; 1985 Oct 15; 15(3):189-97. PubMed ID: 4029755
    [Abstract] [Full Text] [Related]

  • 40. Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase.
    Gurewich V.
    Semin Thromb Hemost; 1989 Apr 15; 15(2):123-8. PubMed ID: 2501871
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.